GlobalSign
A strategic digital signing partnership to secure your signature
LEUVEN, BE / ACCESSWIRE / May 24, 2023 / GMO GlobalSign Ltd. (https://www.globalsign.com), a global Certificate Authority (CA) and leading provider of digital signing, identity and security solutions for the IoT, has announced today its successful establishment of a technology partnership with eXsolut GmbH.
eXsolut has been successfully providing digital signing delivered by GlobalSign's Digital Signing Service (DSS). In that time, hundreds of eXsolut customers have used GlobalSign's DSS product to send digitally signed emails and timestamps to customers throughout Europe. eXsolut sells a smart document management system called TeamDocument a central, on-premises solution optimizing information security and access. Together with GlobalSign, TeamDocument offers the highest security thanks to visibility of the workflow the solution itself provides. Also, editing is restricted to user access within any organization that uses Document Management System (DMS) with a hierarchy of people on different levels,.
eXsolut's CEO Sayit Özdemir explained: "GlobalSign is our new partner for the secure handling of information and documents - the essentials of every modern company.
Together, GlobalSign and eXsolut stand for sustainable and accessible knowledge in times of digital transformation. We are delighted about this partnership!"
DSS is ideally matched with eXsolut's Enterprise Communication and Enterprise Task & Document Management for GlobalSign to manage and sign documents in a safe and digital manner. The main driver for this partnership was that eXsolut required digitally trusted signatures, helping to secure documents to improve traceability and auditability. Bundling eXsolut and GlobalSign together made perfect sense for customers of both organizations across different sectors as it saves time, cost and resources. Many customers chose a digital signature as a complement to DMS due to the increasing need to adhere to compliance and secure communication. Today, digital identity is very important within the manufacturing industry but the pathways to a solution can be complex. Providers offering digital signing within their platform or solution as a feature is the way to digitalize workflows and processes for their customer. To have a clear workflow and approval process is critical. Building a digital identity as an additional layer of credibility adds increased methods to audit.
Account Manager Jerker Svensson emphasizes: "GlobalSign is looking forward to a dynamic and mutually productive partnership with eXsolut, in realizing sophisticated customer projects in the area of document management combined with digital signatures. We are excited about creating customer success together in the future."
About eXsolut
eXsolut has over 20 years' experience as a German software developer. Their focus is on communication, collaboration and knowhow management solutions for organizations in their digital transformation to improve interpersonal workflows and create a sustainable documentation and foundation for collaboration. The idea of quality management is established at the core of the solutions, which is why the solutions receive best practice awards in audits at renowned industrial companies. International customers from different industries and use cases shape the solutions, which are continuously developed and aligned to the processes, needs and wishes of the customers.
About GMO GlobalSign
As one of the world's most deeply-rooted certificate authorities, GMO GlobalSign is the leading provider of trusted identity and security solutions enabling businesses, large enterprises, cloud-based service providers, and IoT innovators worldwide to conduct secure online communications, manage millions of verified digital identities and automate authentication and encryption. Its high-scale Public Key Infrastructure (PKI) and identity solutions support the billions of services, devices, people, and things comprising the IoT. GMO GlobalSign is a subsidiary of GMO GlobalSign Holdings, Inc, a member of the Japan-based GMO Internet Group, has offices in the Americas, Europe and Asia. For more information, visit https://www.globalsign.com.
Media contact
Melanie Faller
France/DACH PR-Manager - EMEA
Phone: + 44 73 111 99 821
E-Mail: Melanie.Faller@globalsign.com
SOURCE: GlobalSign
View source version on accesswire.com:
https://www.accesswire.com/756774/GlobalSign-Partners-with-eXsolut-Throughout-Europe
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
